Moreover, p53-mediated inhibition of CD44 is required to suppress CSC initiation and capacity for tumor growth.26 Our data shows that p53 directly regulates CD133 transcription through binding to p53-binding motifs in the CD133 promoter, indicating that CD133 is a novel p53 target gene. The gene discussed is CD44; the disease is neoplasm.